Navigation Links
EAS Consulting Group Realigns Its Management for Growth
Date:8/7/2012

ALEXANDRIA, Va., Aug. 7, 2012 /PRNewswire/ -- EAS Consulting Group, LLC has realigned its executive structure as part of a long-term strategy for growth. In the latest phase, EAS owner, founder and President Ed Steele has become Chairman and CEO of the company, while Vice President Dean Cirotta has assumed the role of President and Chief Operating Office, and Brett Steele has been named Chief Financial Officer.

The realignment, effective immediately, reflects the company's rapid growth and the desire to meet the expanding demands of the food, dietary supplement, cosmetic, animal and human drug, medical device and tobacco industries.

EAS specializes in Food and Drug Administration regulatory matters. It is staffed by former FDA compliance and inspection officials, and has an extensive network of more than 130 of the industry's most qualified consultants with many years of FDA and industry experience.

Ed Steele formed EAS as an independent company through acquisition in 2006. Since then, EAS has established itself as one of the premier regulatory consulting, training and auditing firms.

Mr. Steele had a distinguished 30-year career at FDA, beginning as a chemist in the New York District and later holding increasingly responsible positions at the Center for Food Safety and Applied Nutrition in Washington, D.C. Upon his retirement from FDA, he served as Vice President of AAC Consulting Group and Kendle International. 

Mr. Cirotta has 25 years of experience in pharmaceuticals firms, including senior management roles with responsibility for regulatory affairs, compliance, quality assurance and corporate management. Immediately prior to joining EAS, he was President and Chief Operating Officer of UPM Pharmaceuticals in Baltimore, Md. Prior to UPM he was President and COO of Leitner Pharmaceuticals. Previously, he was Vice President of Global Regulatory Affairs for the pharmaceutical division of Bausch & Lomb.

Brett Steele has been a partner and Vice President of RailSolutions for 14 years, but has also been involved in financial management at EAS since the company's inception.

Ed Steele will remain active in the daily activities of the company and will provide for the strategic direction of future development. Dean Cirotta will assume day to day management of the technical aspects of the company with responsibility for client relations and personnel management. Brett Steele will oversee all business and financial matters.

For photos, go to http://goo.gl/C1tsI

For more information, contact Ed Steele at (703) 684-4438, e-mail esteele@easconsultinggroup.com or visit http://www.easconsultinggroup.com.

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 


'/>"/>
SOURCE EAS Consulting Group, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
2. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
3. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
4. MiMedx Group Announces Record Second Quarter Results
5. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
6. BioNeutral Group Appoints Mr. Mark Lowenthal as Chief Executive and President
7. BioNeutral Group Expands The Testing Of Its Ygiene Sterilant Against Anthrax Spores
8. BioNeutral Group Appoints A New Member to the Board of Directors
9. Foundation Venture Capital Group Makes Eighth Start-Up Investment
10. Hark! Group demonstrates first heralded single photon source made from silicon
11. Butamax Early Adopters Group surpasses capacity targets with addition of Big River; Membership represents 11 production facilities and nearly 900 million gallons of ethanol capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. , ... tests introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):